Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?

Atherosclerotic cardiovascular disease risk (ASCVD) is an ongoing epidemic, and lipid abnormalities are its primordial cause. Most individuals suffering a first ASCVD event are previously asymptomatic and often do not receive preventative therapies. The cornerstone of primary prevention has been the...

Descripción completa

Detalles Bibliográficos
Autores principales: Piña, Pamela, Lorenzatti, Daniel, Paula, Rita, Daich, Jonathan, Schenone, Aldo L, Gongora, Carlos, Garcia, Mario J, Blaha, Michael J, Budoff, Matthew J, Berman, Daniel S, Virani, Salim S, Slipczuk, Leandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813535/
https://www.ncbi.nlm.nih.gov/pubmed/36619296
http://dx.doi.org/10.1016/j.ajpc.2022.100451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813535/
https://www.ncbi.nlm.nih.gov/pubmed/36619296
http://dx.doi.org/10.1016/j.ajpc.2022.100451

Ejemplares similares